Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma

BACKGROUND: VHL mutation is the most common mutation in clear cell renal cell carcinoma (ccRCC). Here, we developed and validated an immune-related signature to predict the prognosis of ccRCC with VHL mutations. METHODS: VHL mutation status and RNA expression were analysed in the TCGA datasets and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jin, Yan, Aiting, Cao, Wei, Shi, Honglei, Cao, Kai, Liu, Xiaowu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720505/
https://www.ncbi.nlm.nih.gov/pubmed/33372609
http://dx.doi.org/10.1186/s12935-020-01670-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720505/
https://www.ncbi.nlm.nih.gov/pubmed/33372609
http://dx.doi.org/10.1186/s12935-020-01670-5

Ejemplares similares